EDP-305 Targets NASH in Phase 2 Trial Testing Two Doses Against Placebo
Enanta Pharmaceuticals tests its FXR agonist EDP-305 in a completed Phase 2 randomized trial for non-alcoholic steatohepatitis.
20 articles
Enanta Pharmaceuticals tests its FXR agonist EDP-305 in a completed Phase 2 randomized trial for non-alcoholic steatohepatitis.
New research suggests extending overnight fasting from 10 to 16 hours may enhance muscle's ability to use dietary protein for growth.
275-patient study tests novel liver-targeted therapy for NASH, a serious form of fatty liver disease affecting millions worldwide.
Clinical trial tested whether metformin could enhance resistance training benefits for muscle mass and strength in older adults.
A completed trial investigates whether replenishing glutathione precursors can reverse metabolic dysfunction in elderly adults.
A Phase 1 trial tests whether lowering compensatory hyperinsulinemia with diazoxide improves glucose and lipid metabolism in NAFLD patients.
43 overweight adults followed intermittent fasting with 25% calorie reduction, measuring fat loss, muscle preservation, and metabolic changes.
University of Pennsylvania study tests behavioral tools to help people stick with time-restricted eating for blood pressure and weight management.
176-person study explored personalized responses to refined carbs, whole grains, and intermittent fasting for optimal glucose control.
A completed clinical trial tests which dietary approach best controls extreme triglyceride levels in multifactorial chylomicronemia patients.
A completed Maastricht trial tests whether targeted protein and exercise can boost muscle protein synthesis before dialysis becomes necessary.
Czech study reveals how strategic fasting and ketogenic diets can reprogram harmful fat production in obesity.
Maastricht University investigated whether NA, NAM, and tryptophan together could restore mitochondrial function in physically compromised older adults.
Mediterranean diet, resistance training, and diabetes medication combined to combat sarcopenia and improve metabolic health in older adults.
A Phase 2 trial tests a GalNAc-conjugated antisense therapy in familial partial lipodystrophy patients with dangerously high triglycerides.
A Phase IIa trial explores whether the HIF-PHI drug daprodustat can safely replace EPO injections in hemodialysis patients with anemia.
Turkish researchers tested whether adding high-fat, low-carb eating to intermittent fasting beats traditional IF for obesity treatment.
New study reveals how endurance exercise transforms fat-burning brown adipose tissue in just six weeks of training.
Clinical trial tested whether metformin could improve surgical outcomes and reduce hospital stays in non-diabetic older patients.
A sponsored 90-day trial of enhanced-absorption quercetin targeting cholesterol, blood sugar, and metabolic age was terminated before completion.